Sector
PharmaceuticalsOpen
₹32.25Prev. Close
₹32.7Turnover(Lac.)
₹28.42Day's High
₹35.89Day's Low
₹32.2552 Week's High
₹52.152 Week's Low
₹27.33Book Value
₹16.02Face Value
₹10Mkt Cap (₹ Cr.)
22.82P/E
85.49EPS
0.41Divi. Yield
07 Sep 2024
12:00 AM
AGM
Announcement Date: 07 Sep, 2024
6 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.51 | 6.51 | 6.51 | 6.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.61 | 3.19 | 2.86 | 2.05 |
Net Worth | 10.12 | 9.7 | 9.37 | 8.56 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 56.64 | 59.94 | 71.83 | 81.15 |
yoy growth (%) | -5.52 | -16.54 | -11.48 | 415.22 |
Raw materials | -46.72 | -49.45 | -57.11 | -65.41 |
As % of sales | 82.49 | 82.5 | 79.5 | 80.6 |
Employee costs | -3.35 | -3.97 | -2.8 | -3.05 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.92 | -1.16 | 1.65 | 1.22 |
Depreciation | -0.27 | -0.29 | -0.2 | -0.2 |
Tax paid | -0.09 | 0.43 | -0.48 | -0.27 |
Working capital | 0.39 | 0.42 | 1.51 | 1.49 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -5.52 | -16.54 | -11.48 | 415.22 |
Op profit growth | -230.72 | -145.92 | 27.25 | 629.77 |
EBIT growth | -188.2 | -162.5 | 31.24 | 237.93 |
Net profit growth | -213.53 | -162.95 | 22.29 | 459 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,663.15 | 93.33 | 3,99,045.4 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,841.15 | 82.22 | 1,81,611.04 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,477.3 | 24.79 | 1,19,322.68 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,339.05 | 59.72 | 1,13,003.55 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,259.2 | 19.53 | 1,05,090.54 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Sanjeev Kumar
Non Executive Director
Him Jyoti
Whole Time Director
Sanjay Dhir
Independent Director
Anurag Malhotra
Independent Director
Kuldeep Singh
Company Sec. & Compli. Officer
Manju Bala
Plot No 194-195 3rd Flr Pha-II,
Industrial Area Ram Darbar,
Chandigarh - 160002
Tel: 91-172-4651105/3920738
Website: http://www.zenlabsethica.com
Email: preetremedies@gmail.com ; queries@zenlabsethica.co
E-2/3 Saki Vihar Rd,
Ansa Indl Estate, Saki Naka Andheri-E,
Mumbai - 400 072
Tel: 91-22-40430200
Website: www.bigshareonline.com
Email: info@bigshareonline.com
Summary
Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that ...
Read More
Reports by Zenlabs Ethica Ltd
What is the Zenlabs Ethica Ltd share price today?
What is the Market Cap of Zenlabs Ethica Ltd?
What is the PE and PB ratio of Zenlabs Ethica Ltd?
What is the 52 Week High and Low of Zenlabs Ethica Ltd?
What is the CAGR of Zenlabs Ethica Ltd?
What is the shareholding pattern of Zenlabs Ethica Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.